Stem-Cell Transplantation
Gemtuzumab ozogamicin increases VOD risk in myeloablative stem cell graft recipients
Published in Medical Devices and Surgical Technology Week, October 19th, 2003
GO, "a monoclonal antibody used in the treatment of acute myelogenous leukemia (AML) has been linked to the development of veno-occlusive disease (VOD)," scientists in Boston noted.
To "determine whether GO exposure prior to allogeneic SC transplantation increases the risk of developing VOD," M. Wadleigh and coauthors at the Dana-Farber Cancer Institute "conducted a retrospective study of 62 patients with previously treated AML/MDS (myelodysplastic syndrome) who underwent allogeneic stem cell (SC) transplantation at our institution from December...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Congestive Heart Failure
Respiratory pacing device found beneficial in heart failure - Drug Delivery
Ultra-tiny "bio-nano" motors studied - Bladder Cancer
Widespread adoption of laparoscopic cystectomy may increase death rate - Diagnostic Imaging
Intermittent-bolus contrast imaging is valuable for studying tumor perfusion - Fetal Medicine
Liquid flow has a cooling effect on ultrasound-induced heating in study models - Radiography
Signal detection in digital radiography investigated - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
